Moreover, in the subgroup analysis the gene signature showed better predictive power for patients in the TP53 mutant group, ESCC group, and ESAD group (Figures 6A–C), indicating that this model has good predictive ability in esophageal cancer. This evidence concerns the gene TP53 and esophageal cancer.